Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 8, 2023
Product Development
CVOT data for Novo’s Wegovy set bar for health benefit in obesity
Big market cap gains for Novo, Lilly as GLP-1 cuts CV risk by 20%
BioCentury | Feb 19, 2021
Product Development
What works, what doesn’t and what’s next for COVID-19: Data Byte
A COVID-19 report card and look ahead to the next late-stage readouts
BioCentury | Feb 6, 2020
Deals
Beyond Keytruda: How Merck envisions innovation and growth after a spinout
Recent and future BD will help drive Merck's innovation, while slower-growing businesses are headed for a new entity
BioCentury | Jan 29, 2020
Product Development
Industry leaders applaud CVS zero co-pay diabetes drug access
CVS is answering the call to decrease the cost burden of diabetes medications on patients
BioCentury | Dec 21, 2019
Politics, Policy & Law
U.S. drug industry hopes China deal ends stealth attack on IP
Innovators hope trade deal stops China's stealth war on IP
BioCentury | Nov 13, 2019
Clinical News
Hua Phase III diabetes data make good on glucokinase but disappoint investors
Hua’s glucokinase activator notches a Phase III win for the long-pursued target
BioCentury | Sep 25, 2019
Company News
Sept. 24 Company Quick Takes: FDA approves smallpox vaccine; plus Epidyolex, Vitrakvi, Oral semaglutide, Takeda-Evotec, Guerbet-IBM Watson
BioCentury | Aug 2, 2019
Financial News
Aug. 2 Financial Quick Takes: Rakuten Medical bags another $100M; plus CGeneTech, Zecen, Qyuns and more
Items per page:
1 - 10 of 99